An introductory GLP-1 offer can lower the first payment without lowering the ongoing plan. The effect is especially easy to miss when a membership promotion excludes medicine or a four-week supply later renews on a longer term. These five routes keep the later bill in view.
Top Five Weight Loss compares current first-charge and regular structures rather than collecting discount banners. Some pages provide explicit later amounts; another promotion needs its selected duration confirmed. A clear introduction is useful information, but it is not proof of the cheapest ongoing treatment or a reason to change the prescription.
What makes this shortlist useful
Record the exact plan, first charge, first supply period, ordinary renewal and amount due for the next term. Separate access-only discounts from medicine-inclusive offers. A quarterly equivalent should show its full payment period, and a microdose program should not become the price of standard treatment. Confirm promotion eligibility before using any floor in a personal budget. Read the related care guide for a wider treatment discussion.
1. CoreAge Rx: a stated monthly rate without a separate access fee
CoreAge’s offer is a clinician-reviewed compounded pathway with separate semaglutide and tirzepatide product pages. Compare the actual prescribed preparation and pharmacy supply before interpreting the monthly price. The ingredient names do not establish that its compound is the same finished drug as Wegovy or Zepbound. The ingredient-specific rate offers a different contrast to large introductory discounts. Confirm the actual regular supply and refund terms; a straightforward advertised price still does not establish every individualized order condition.
CoreAge’s current product pages list compounded semaglutide at $99 per month and compounded tirzepatide at $149, with no membership fee and free delivery if prescribed. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
2. Enhance.MD: a first four-week discount with later cost
Enhance.MD’s standard compounded programs identify four-week medicine supplies, ongoing support and periodic metabolic labs. Their first-month discounts and later rates differ substantially. That makes the initial bill a different comparison question from whether the ongoing program fits a sustainable care budget. Enhance clearly states different initial and ongoing figures for both compounds. Retain the four-week unit and selected ingredient so the first low payment cannot stand in for an ongoing calendar-month treatment budget.
Enhance.MD currently lists compounded semaglutide at $49 for the first month and $212 afterward; tirzepatide is $99 initially and $280 afterward. Its cards describe four weeks of medication, provider support and metabolic labs every six months. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
Read the full Enhance.MD review to compare the care pathway, prescription and recurring order.
3. Mochi Health: a new-member discount on access only
Mochi’s current membership provides physician and care-team access, coaching and support while medicine and diagnostics remain separate. Its catalogue contains both branded and compounded treatments. The program choice therefore involves the selected formulation as well as the care relationship and recurring access charge. The $39 introduction concerns eligible membership, which then increases to $79 with medication and diagnostics extra. A medicine-card minimum should be added only after the selected strength, amount and fulfillment are confirmed.
Mochi currently offers eligible new subscribers a $39 first membership month, then $79 per month, with medication and diagnostics excluded. Promotion availability varies by state. Its compounded medication cards say semaglutide as low as $60 and tirzepatide as low as $90, but quantity, selected strength and fulfillment terms need confirmation; those are additional floors, not complete membership-inclusive orders.
Read the full Mochi Health review to compare the care pathway, prescription and recurring order.
4. Ro: initial membership followed by term choices
Ro Body makes the care membership and medication bill separate. Its current options include FDA-approved products, with provider access and insurance assistance within membership. A person comparing the program should identify the exact medicine and payment term rather than treating the smallest access fee as treatment-inclusive. Ro’s $39 first month leads to different regular membership terms. The lower annual equivalent requires prepayment and medicine remains extra, so the patient should compare the actual selected next access bill and separate pharmacy order.
Ro currently charges $39 for the first membership month, then $149 month-to-month or a $74 monthly equivalent on annual prepayment. Six- and three-month equivalents are $89 and $99, respectively. Medication is extra and depends on product, dose and coverage; branded-injection starting offers have dose and eligibility conditions. Confirm the entire advance charge, next renewal and pharmacy supply.
Read the full Ro review to compare the care pathway, prescription and recurring order.
5. Noom Med: several introductory pathways
Noom’s medical programs combine treatment access with behavior-change tools and coaching resources. Several plan names conceal important differences in medicine inclusion and billing. Identify whether the chosen pathway is standard compounded treatment, a separate microdose program or care for a branded prescription. Noom’s program names distinguish standard compounded, plus, branded-care and microdose offers. The lower introduction for one pathway should not become another plan’s treatment price, and quarterly renewal needs its complete amount visible.
Noom currently lists its compounded GLP-1Rx program at $129 for the first four-week supply, then $249 monthly equivalent billed quarterly, and GLP-1Rx Plus at $149 initially then $299 equivalent quarterly. Its branded-medication care route is $39 initially then $129 equivalent quarterly, with medicine extra. The $49 microdose introduction is a separate plan, not the standard injection price.
Read the full Noom Med review to compare the care pathway, prescription and recurring order.
Choose the next step, then confirm the order
Compare the first offer with the plan that would continue after it. Ask when the next charge is scheduled and how cancellation works before committing. A lower initial payment can make access easier while still leading to a more expensive ongoing order or a larger prepaid renewal.
An introductory offer does not guarantee eligibility, results or suitability of a compound. A clinician should determine treatment and explain the actual preparation. Keep the pharmacy label and clinical review central rather than using a time-limited promotion to accelerate a medical decision.
Continue with Best GLP-1 programs for long-term care planning: five continuing-care structures and Cheapest semaglutide monthly plans without annual prepayment: five comparisons.
Explore the full comparison table or read the CoreAge Rx review for pricing, care, and billing details.
